Erin M. MacKenzie

544 total citations
26 papers, 411 citations indexed

About

Erin M. MacKenzie is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Erin M. MacKenzie has authored 26 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Erin M. MacKenzie's work include Treatment of Major Depression (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Tryptophan and brain disorders (5 papers). Erin M. MacKenzie is often cited by papers focused on Treatment of Major Depression (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Tryptophan and brain disorders (5 papers). Erin M. MacKenzie collaborates with scholars based in Canada, United States and Denmark. Erin M. MacKenzie's co-authors include Glen B. Baker, Dmitriy Matveychuk, Mee‐Sook Song, Darrell D. Mousseau, J. Odontiadis, Serdar Dursun, Jean‐Michel Le Mellédo, Trevor I. Prior, Paul L. Wood and Satyabrata Kar and has published in prestigious journals such as Journal of Affective Disorders, Schizophrenia Bulletin and Behavioural Brain Research.

In The Last Decade

Erin M. MacKenzie

25 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin M. MacKenzie Canada 12 122 108 90 83 69 26 411
M. Amin Khan United States 13 205 1.7× 185 1.7× 149 1.7× 92 1.1× 70 1.0× 16 579
Encarnación Camacho Spain 8 116 1.0× 95 0.9× 60 0.7× 93 1.1× 129 1.9× 10 533
Katarzyna Kamińska Poland 19 188 1.5× 343 3.2× 79 0.9× 69 0.8× 45 0.7× 30 589
Cristiane Batassini Brazil 13 126 1.0× 112 1.0× 52 0.6× 41 0.5× 145 2.1× 17 477
Bettina E. Kalisch Canada 14 185 1.5× 171 1.6× 64 0.7× 61 0.7× 167 2.4× 31 517
Kaori Kubota Japan 12 139 1.1× 85 0.8× 46 0.5× 41 0.5× 109 1.6× 38 431
Anna Dziubina Poland 16 188 1.5× 297 2.8× 86 1.0× 74 0.9× 70 1.0× 31 567
Alessia Costa Italy 14 300 2.5× 64 0.6× 130 1.4× 64 0.8× 109 1.6× 26 559
T. P. Serkova Russia 9 142 1.2× 84 0.8× 113 1.3× 30 0.4× 117 1.7× 21 384
V. Chan-Palay Switzerland 6 105 0.9× 139 1.3× 97 1.1× 41 0.5× 129 1.9× 13 412

Countries citing papers authored by Erin M. MacKenzie

Since Specialization
Citations

This map shows the geographic impact of Erin M. MacKenzie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin M. MacKenzie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin M. MacKenzie more than expected).

Fields of papers citing papers by Erin M. MacKenzie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin M. MacKenzie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin M. MacKenzie. The network helps show where Erin M. MacKenzie may publish in the future.

Co-authorship network of co-authors of Erin M. MacKenzie

This figure shows the co-authorship network connecting the top 25 collaborators of Erin M. MacKenzie. A scholar is included among the top collaborators of Erin M. MacKenzie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin M. MacKenzie. Erin M. MacKenzie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chokka, Pratap, Jeffrey Habert, Zahinoor Ismail, et al.. (2025). Patient-reported efficacy of adjunctive brexpiprazole in major depressive disorder in a phase 4, open-label, interventional study. Current Medical Research and Opinion. 41(8). 1511–1522.
2.
3.
McIntyre, Roger S., et al.. (2024). Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress. Journal of Clinical Psychopharmacology. 44(2). 133–140. 2 indexed citations
4.
McIntyre, Roger S., Zahinoor Ismail, Maı̈a Miguelez, et al.. (2023). Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data. Journal of Psychiatric Research. 162. 71–78. 4 indexed citations
5.
Katzman, Martin A., et al.. (2022). Efficacy of adjunctive brexpiprazole on symptom clusters of major depressive disorder: A post hoc analysis of four clinical studies. Journal of Affective Disorders. 316. 201–208. 5 indexed citations
6.
Weiss, Catherine, et al.. (2022). Exploring life engagement from the perspective of patients with major depressive disorder: a study using patient interviews. Journal of Patient-Reported Outcomes. 6(1). 111–111. 8 indexed citations
7.
Matveychuk, Dmitriy, Erin M. MacKenzie, Mee‐Sook Song, et al.. (2021). Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine. Cellular and Molecular Neurobiology. 42(1). 225–242. 21 indexed citations
8.
MacKenzie, Erin M., et al.. (2021). Development of the chicken skull: A complement to the external staging table of Hamburger and Hamilton. The Anatomical Record. 304(12). 2726–2740. 9 indexed citations
9.
Baker, Glen B., Dmitriy Matveychuk, Erin M. MacKenzie, et al.. (2019). Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine. Chemico-Biological Interactions. 304. 139–147. 21 indexed citations
10.
MacKenzie, Erin M., et al.. (2015). Inhibition of p53 attenuates ischemic stress-induced activation of astrocytes. Neuroreport. 26(14). 862–869. 14 indexed citations
11.
12.
Song, Mee‐Sook, et al.. (2013). An update on amine oxidase inhibitors: Multifaceted drugs. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 44. 118–124. 77 indexed citations
13.
MacKenzie, Erin M., et al.. (2012). d-serine and schizophrenia: an update. Expert Review of Neurotherapeutics. 12(7). 801–812. 26 indexed citations
14.
MacKenzie, Erin M., et al.. (2012). Monoamine Oxidase Inhibitors and Neuroprotection. American Journal of Therapeutics. 19(6). 436–448. 43 indexed citations
15.
Chue, Pierre, et al.. (2012). The pharmacology and formulation of paliperidone extended release. Expert Review of Neurotherapeutics. 12(12). 1399–1410. 20 indexed citations
16.
MacKenzie, Erin M., Afshin Fassihi, Asghar Davood, et al.. (2008). N-Propynyl analogs of β-phenylethylidenehydrazines: Synthesis and evaluation of effects on glycine, GABA, and monoamine oxidase. Bioorganic & Medicinal Chemistry. 16(17). 8254–8263. 7 indexed citations
17.
MacKenzie, Erin M., J. Odontiadis, Jean‐Michel Le Mellédo, Trevor I. Prior, & Glen B. Baker. (2007). The Relevance of Neuroactive Steroids in Schizophrenia, Depression, and Anxiety Disorders. Cellular and Molecular Neurobiology. 27(5). 541–574. 49 indexed citations
18.
MacKenzie, Erin M., et al.. (2007). Phenelzine Causes an Increase in Brain Ornithine that is Prevented by Prior Monoamine Oxidase Inhibition. Neurochemical Research. 33(3). 430–436. 13 indexed citations
19.
Odontiadis, J., Erin M. MacKenzie, Sridhar Natesan, et al.. (2006). Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection. Journal of Chromatography B. 850(1-2). 544–547. 3 indexed citations
20.
Howland, John G., et al.. (2003). Electrical stimulation of the hippocampus disrupts prepulse inhibition in rats: frequency- and site-dependent effects. Behavioural Brain Research. 152(2). 187–197. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Amin Khan Breakdown of academic impact, for papers by Encarnación Camacho Breakdown of academic impact, for papers by Katarzyna Kamińska Breakdown of academic impact, for papers by Cristiane Batassini Breakdown of academic impact, for papers by Bettina E. Kalisch Breakdown of academic impact, for papers by Kaori Kubota Breakdown of academic impact, for papers by Anna Dziubina Breakdown of academic impact, for papers by Alessia Costa Breakdown of academic impact, for papers by T. P. Serkova Breakdown of academic impact, for papers by V. Chan-Palay
Rankless by CCL
2026